In this study, DHP significantly inhibited the aberrant expression of TLR4/NF-κB pathway proteins, suggesting that DHP may attenuate the inflammatory response in NAFLD through this pathways (Figures 6C–E). This evidence concerns the gene NFKB1 and metabolic dysfunction-associated steatotic liver disease.